Subscribe to magazine
Subscribe to newsletters
Computed Tomography (CT)
Magnetic Resonance Imaging (MRI)
Radiation Dose management
Intravascular imaging systems
Peripheral Artery Disease
Leads, implantable devices
Implantable cardioverter defibrillators (ICD)
Cardiac resynchronization therapy devices (CRT)
Heart Valve Technology
Left atrial appendage (LAA) occluders
Structural heart occluders/closure devices
Clinical decision support
January 26, 2012
Amorcyte Enrolls First Patient in PreSERVE Phase II Trial for Acute Myocardial Infarction
January 26, 2012 — Amorcyte LLC, a NeoStem company, announced the enrollment of the first patient in the Amorcyte...
January 13, 2012
Stem Cell Company Amorcyte Announces Expansion of Intellectual Property
January 13, 2012 — Amorcyte Inc., a NeoStem Inc. company, announced the expansion of intellectual property protection...
October 24, 2011
NeoStem, Amorcyte to Initiate Phase 2 Stem Cell Product Trial
October 24, 2011 — NeoStem Inc. and Amorcyte Inc announced the closing of their previously publicized merger...
August 19, 2011
NeoStem Provides Update on Amorcyte Stem Cell Treatment Clinical Progress
August 19, 2011 — NeoStem Inc., an international biopharmaceutical company, reported progress toward commencement of a...
Scranton Gillette Communications
. All Rights Reserved.
Terms and Conditions